公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2015 | A multicenter, prospective, longitudinal registry of prostate cancer in Asia | Uemura, H.; Ye, D.; Wu, T-L.; Lee, J-Y.; Chong, Y. L.; Razack, A. H. A.; Pripatnanont, C.; Chiong, E.; Lau, W. K. O.; Kanesvaran, R.; Li, C.; Rawal, S.; Tongaonkar, H.; Pu, Y-S.; Santingamkun, A.; Lojanapiwat, B.; Liang, H.; Mah, K. W.; Losio, M. van Kooten; Liu, Y.; 蒲永孝 | Ann. Oncol. | | | |
1989 | The Application of Voiding Sonography in the Diagnosis of Voiding Dysfunction | PU, YEONG-SHIAU; KUO, HANN-CHORNG; 蒲永孝; 郭漢崇 | 慈濟醫學雜誌,v.1 | | | |
1999 | Detection of Serum Anti-P53 Antibody in Patients with Renal Cell Carcinoma | HSU, FU-SHUN; CHEN, JUN; HUANG, CHAO-YUAN; LIU, SHIO-HUEI; GUAN, JING-YI; LAI, MING-KUEN; PU, YEONG-SHIAU; 許富順; 陳淳; 黃昭淵; 呂秀慧; 官靜儀; 賴明坤; 蒲永孝 | JOURNAL OF UROLOGY | | | |
2016 | Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study | Ye, D.; Ahn, H.; Pu, Y-S.; Weiqing, H.; Xie, L-P.; Huang, S-P.; Wu, H-C.; Ma, L.; Yamada, S.; Noda, S.; Sun, Y.; 蒲永孝 | Ann. Oncol. | 0 | 1 | |
2016 | Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study | Ye, D.; Ahn, H.; Pu, Y-S.; Han, W.; Xie, L-P.; Huang, S-P.; Wu, H-C.; Ma, L.; Qi, J.; Zhou, F.; Sun, G.; Chen, L.; Xue, B.; Yamada, S.; Saito, M.; Suga, K.; Sun, Y.; 蒲永孝 | Ann. Oncol. | | | |
2006 | Epidermal Growth Factor Receptor Inhibitor (Pd168393) Potentiates Cytotoxic Effects of Paclitaxel against Androgen-Independent Prostate Cancer Cells | PU, YEONG-SHIAU; HSIEH, MIN-WEI; WANG, CHUANG-WEI; LIU, GUANG-YAW; HUANG, CHAO-YUAN; LIN, CHIA-CHI; GUAN, JING-YI; LIN, SHINNE- REN; HOUR, TZYH-CHYUAN; 蒲永孝; 謝旻娓; 王壯維; 劉光耀; 黃昭淵; 林家齊; 官靜儀; 林信仁; 侯自銓 | BIOCHEMICAL PHARMACOLOGY | | | |
2009 | Lymphovascular invasion predicts poor outcome of urothelial carcinoma of renal pelvis after nephroureterectomy | Chung, Shiu-Dong; Wang, Shuo-Meng; Lai, Ming-Kuen; Huang, Chao-Yuan; Liao, Chun-Hou; Huang, Kuo-How; Pu, Yeong-Shiau; Chueh, Shih-Chieh; Yu, Hong-Jeng; 鍾旭東; 王碩盟; 賴明坤; 黃昭淵; 廖俊厚; 黃國皓; 蒲永孝; 闕士傑; 余宏政 | BJU INTERNATIONAL | | | |
2004 | Negative Modulation of Androgen Receptor Transcriptional Activity by Daxx | Lin, D.-Y.; Fang, H.-I; Ma, A.-H.; Huang, Y.-S.; Pu, Y.-S.; Jenster, G.; Kung, H.-J.; Shih, H.-M.; 蒲永孝 | MOLECULAR AND CELLULAR BIOLOGY | | | |
1992 | Nuclear Ploidy Analysis of Bladder Cancer---Comparison of the Ploidy Patterns between the Serially Recurrent Tumors | PU, YEONG-SHIAU; HSIEH, TEH-SHENG; SU, IH-JEN; TSAI, TSONG-CHANG; HSUEH, WEN-CHI; 蒲永孝; 謝德生; 蘇益仁; 蔡崇璋; 薛文綺 | 中華民國癌症醫學會雜誌,v.8 | | | |
1999 | Prostate Cancer in Taiwan | PU, YEONG-SHIAU; 蒲永孝 | 臺灣醫學,v.3 | | | |
1989 | Prostatic Cyst | PU, YEONG-SHIAU; CHIANG, HAN-SUN; CHIU, TSU-YIH; 蒲永孝; 江漢聲; 丘祖毅 | 中華民國醫用超音波學會雜誌,v.6 | | | |
1999 | 一種新抑癌基因 C-CAM在前列腺癌之表現及預後價值 | 蒲永孝 | | | | |
1997 | 人類泌尿上皮癌抗藥性之反制 (II)--化學藥物誘發與細胞凋亡有關之分子變化 | 蒲永孝 | | | | |
1996 | 人類泌尿上皮癌抗藥性之反制-Tamoxifen及Protein Kinase C 抑制劑之作用探討 | 蒲永孝 | | | | |
2008 | 以DNA異結物切除能力來預測膀胱癌放射線敏感性 (新制多年期第1年) | 蒲永孝 | | | | |
2006 | 以DNA異結物切除能力來預測膀胱癌放射線敏感性 (新制多年期第2年) | 蒲永孝 | | | | |
2000 | 台灣烏腳病流行區泌尿系統移形上皮癌生物分子學之採討研究─無機砷暴露後泌尿上皮細胞之分子變化及砷在泌尿上皮癌之抗藥性機制(1/3) | 蒲永孝 | | | | |
2001 | 台灣烏腳病流行區泌尿系統移形上皮癌生物分子學之採討研究─無機砷暴露後泌尿上皮細胞之分子變化及砷在泌尿上皮癌之抗藥性機制(2/3) | 蒲永孝 | | | | |
2002 | 台灣烏腳病流行區泌尿系統移形上皮癌生物分子學之採討研究─無機砷暴露後泌尿上皮細胞之分子變化及砷在泌尿上皮癌之抗藥性機制(3/3) | 蒲永孝 | | | | |
2000 | 找尋治療賀爾蒙抗性前列腺癌之新方法(1/3) | 蒲永孝 | | | | |